Epilepsy Trial, Recruiting (NCT06667232)

Epilepsy Trial, Recruiting NCT06667232 Sponsor: Xuanwu Hospital, Beijing Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06667232 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have epilepsy that has not been controlled by medication (drug-resistant epilepsy) and it starts in one specific area of the brain (focal epilepsy)
Your doctors have recommended a specific brain monitoring procedure called SEEG (where small electrodes are placed in the brain) as part of planning for possible epilepsy surgery
You will be staying in a specialist epilepsy unit for an extended period to have your brain activity recorded and analysed using the SEEG electrodes
You are willing to confirm in writing that you do not object to taking part in the study

Who may not be able to join:

You are pregnant (as SEEG is not suitable during pregnancy)
You have a psychiatric disorder
You have a history of psychotic disorders (such as psychosis)
You have a history of a serious head injury, or you have another ongoing or previous neurological condition affecting the brain or nervous system (confirm with trial site for exact definitions)
If you experience any complications during the procedure to place the SEEG electrodes, you would be removed from the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Liankun Ren, MD, Xuanwu Hospital, Beijing

Phone: +86 13681576621

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06667232

Sponsor: Xuanwu Hospital, Beijing

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: +86 13681576621

More information: https://clinicaltrials.gov/study/NCT06667232

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have epilepsy that has not been controlled by medication (drug-resistant epilepsy) and it starts in one specific area of the brain (focal epilepsy)
Your doctors have recommended a specific brain monitoring procedure called SEEG (where small electrodes are placed in the brain) as part of planning for possible epilepsy surgery
You will be staying in a specialist epilepsy unit for an extended period to have your brain activity recorded and analysed using the SEEG electrodes
You are willing to confirm in writing that you do not object to taking part in the study

Who may not be able to join:

You are pregnant (as SEEG is not suitable during pregnancy)
You have a psychiatric disorder
You have a history of psychotic disorders (such as psychosis)
You have a history of a serious head injury, or you have another ongoing or previous neurological condition affecting the brain or nervous system (confirm with trial site for exact definitions)
If you experience any complications during the procedure to place the SEEG electrodes, you would be removed from the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Xuanwu Hospital, Beijing

Registry

ClinicalTrials.gov

Start date

18 January 2025

Est. completion

25 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Modulation Factor; EEG power in spectral frequency bands; Phase Locking Value

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov